Cas:75919-92-5 1-[4-(4-Nitrophenoxy)phenyl]ethanone manufacturer & supplier

We serve Chemical Name:1-[4-(4-Nitrophenoxy)phenyl]ethanone CAS:75919-92-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-[4-(4-Nitrophenoxy)phenyl]ethanone

Chemical Name:1-[4-(4-Nitrophenoxy)phenyl]ethanone
CAS.NO:75919-92-5
Synonyms:1-[4-(4-Nitrophenoxy)phenyl]ethanone;Ethanone, 1-[4-(4-nitrophenoxy)phenyl]-;4-acetyl-4′-nitrodiphenyl ether;MFCD00052956
Molecular Formula:C14H11NO4
Molecular Weight:257.241
HS Code:

Physical and Chemical Properties:
Melting point:79-81°C
Boiling point:398.0±22.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.597
PSA:72.12000
Exact Mass:257.068817
LogP:3.63

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-[4-(4-Nitrophenoxy)phenyl]ethanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00052956 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00052956 Use and application,MFCD00052956 technical grade,usp/ep/jp grade.


Related News: The continued momentum follows other major milestones and announcements from this year, including a $125 million Series D raise, $1.73 billion valuation, and key leadership team additions such as Prince Harry, The Duke of Sussex, as the company’s Chief Impact Officer. 6-(4-chloro-6-ethoxy-1,3,5-triazin-2-yl)-2-methyl-1,3,6,2-dioxazaphosphocane 2-sulfide manufacturers Contract research organisation Charles River Laboratories International Inc. today announced plans for an €8M expansion of its testing capabilities at its Ballina, Co. Mayo site that will give an additional 1,500m2 of lab space and create up to 90 new skilled roles over the next three years. (Z)-3,4-dihydroxy-11,24,34,44,54,61-hexaoxid-3-ene-2,5-dione compound with 8-(13,24,33,43,53,63-hexaoxin-2-yl)-2-hydroperoxy-8H-13,24,44,53,63,74,83,103,124,134-hexaoxino[1,2-a]pentaoxolo[4,3-e]hexaoxin-10-ol (1:1) suppliers As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders. 3-(1,3-dibenzylimidazolidin-2-yl)phenol vendor & factory.